Grainger David J Insider Trades

Insider Trading History

Track insider trading activity for Grainger David J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $38.4M 962,790 shares
Last Trade
Dec 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.4k 4,700 shares
$7.96
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $38.6M 967,490 shares
Last Trade
Sep 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.4k 4,700 shares
$6.47
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $38.7M 972,190 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.3k 4,290 shares
$5.90
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $38.9M 976,480 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.8k 4,825 shares
$3.90
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $39.1M 981,305 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$443k 115,000 shares
$3.85
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $36.3M 911,259 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.74k 2,497 shares
$3.10
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $36.2M 908,575 shares
Last Trade
Oct 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.3k 2,853 shares
$3.95
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $36.1M 906,602 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.4k 7,154 shares
$4.25
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $36.3M 911,428 shares
Last Trade
Sep 30, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.47k 2,328 shares
$4.07
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $36.4M 913,756 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$517k 100,000 shares
$5.17
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $7.97M 200,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.91M 200,000 shares
$9.53
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $1.1M 27,500 shares
Last Trade
Jan 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$249k 27,500 shares
$9.05
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $6.97M 175,000 shares
Last Trade
Nov 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.45M 175,000 shares
$14.01
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Innovation Officer
Holding Value $32.4M 813,756 shares
Last Trade
Oct 01, 2021 Sale
$2.48M 150,000 shares
$16.52
$39.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up